AFP and hepatocellular carcinoma: The diagnostic efficacy of a single detection of tumor markers for HCC is limited; serum AFP, AFP-L3% and PIVKA-II still lack high sensitivity and specificity in the diagnosis of HCC (Dong et al., 2023; Hanif et al., 2022).